GW Pharmaceuticals Plc.
GW Pharmaceuticals Plc (NASDAQ:GWPH) is developing a portfolio of cannabinoid medicines, including Sativex for the treatment of MS spasticity and cancer pain, and Epidiolex for the treatment of childhood epilepsy.
Latest News & Stories on GW Pharmaceuticals Plc. (NASDAQ:GWPH) (LSE:GWP)
Some elements on this page did not load. Refresh your site & try again.